These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 35541895)

  • 1. CIRBP-OGFR axis safeguards against cardiomyocyte apoptosis and cardiotoxicity induced by chemotherapy.
    Liu C; Cheng X; Xing J; Li J; Li Z; Jian D; Wang Y; Wang S; Li R; Zhang W; Shao D; Ma X; Chen X; Shen J; Shi C; Guo Z; Wang W; Fan T; Liu L; Tang H
    Int J Biol Sci; 2022; 18(7):2882-2897. PubMed ID: 35541895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting OGF/OGFR signal to mitigate doxorubicin-induced cardiotoxicity.
    Chen X; Jian D; Xing J; Cheng X; Wang C; Wang C; Pan J; Qi X; Wang S; Li Z; Liu Y; Jian L; Tang H
    Free Radic Biol Med; 2024 Oct; 223():398-412. PubMed ID: 39122201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Astrocyte proliferation is regulated by the OGF-OGFr axis in vitro and in experimental autoimmune encephalomyelitis.
    Campbell AM; Zagon IS; McLaughlin PJ
    Brain Res Bull; 2013 Jan; 90():43-51. PubMed ID: 22985690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of cyclin-dependent kinase 2 protects against doxorubicin-induced cardiomyocyte apoptosis and cardiomyopathy.
    Xia P; Liu Y; Chen J; Coates S; Liu DX; Cheng Z
    J Biol Chem; 2018 Dec; 293(51):19672-19685. PubMed ID: 30361442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth inhibition of thyroid follicular cell-derived cancers by the opioid growth factor (OGF) - opioid growth factor receptor (OGFr) axis.
    McLaughlin PJ; Zagon IS; Park SS; Conway A; Donahue RN; Goldenberg D
    BMC Cancer; 2009 Oct; 9():369. PubMed ID: 19835629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of Tenon's capsule fibroblast cell proliferation by the opioid growth factor and the opioid growth factor receptor axis.
    Klocek MS; Sassani JW; Donahue RN; McLaughlin PJ; Zagon IS
    Invest Ophthalmol Vis Sci; 2010 Oct; 51(10):5054-61. PubMed ID: 20463323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective oncotarget for gynecological cancer: Opioid growth factor (OGF) - opioid growth factor receptor (OGFr) axis.
    Qu N; Wang X; Meng Y; Shan F
    Int Immunopharmacol; 2019 Oct; 75():105723. PubMed ID: 31408839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opioid growth factor-opioid growth factor receptor axis is a physiological determinant of cell proliferation in diverse human cancers.
    Zagon IS; Donahue RN; McLaughlin PJ
    Am J Physiol Regul Integr Comp Physiol; 2009 Oct; 297(4):R1154-61. PubMed ID: 19675283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Curcumin attenuates doxorubicin-induced cardiotoxicity via suppressing oxidative stress and preventing mitochondrial dysfunction mediated by 14-3-3γ.
    He H; Luo Y; Qiao Y; Zhang Z; Yin D; Yao J; You J; He M
    Food Funct; 2018 Aug; 9(8):4404-4418. PubMed ID: 30063064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adiponectin agonist ADP355 ameliorates doxorubicin-induced cardiotoxicity by decreasing cardiomyocyte apoptosis and oxidative stress.
    Zhao D; Xue C; Li J; Feng K; Zeng P; Chen Y; Duan Y; Zhang S; Li X; Han J; Yang X
    Biochem Biophys Res Commun; 2020 Dec; 533(3):304-312. PubMed ID: 32958254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rosmarinic acid alleviates cardiomyocyte apoptosis via cardiac fibroblast in doxorubicin-induced cardiotoxicity.
    Zhang X; Zhu JX; Ma ZG; Wu HM; Xu SC; Song P; Kong CY; Yuan YP; Deng W; Tang QZ
    Int J Biol Sci; 2019; 15(3):556-567. PubMed ID: 30745842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nucleocytoplasmic distribution of opioid growth factor and its receptor in tongue epithelium.
    Zagon IS; Ruth TB; McLaughlin PJ
    Anat Rec A Discov Mol Cell Evol Biol; 2005 Jan; 282(1):24-37. PubMed ID: 15584033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T lymphocyte proliferation is suppressed by the opioid growth factor ([Met(5)]-enkephalin)-opioid growth factor receptor axis: implication for the treatment of autoimmune diseases.
    Zagon IS; Donahue RN; Bonneau RH; McLaughlin PJ
    Immunobiology; 2011 May; 216(5):579-90. PubMed ID: 20965606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Doxorubicin induces cardiomyocyte pyroptosis via the TINCR-mediated posttranscriptional stabilization of NLR family pyrin domain containing 3.
    Meng L; Lin H; Zhang J; Lin N; Sun Z; Gao F; Luo H; Ni T; Luo W; Chi J; Guo H
    J Mol Cell Cardiol; 2019 Nov; 136():15-26. PubMed ID: 31445005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. B lymphocyte proliferation is suppressed by the opioid growth factor-opioid growth factor receptor axis: Implication for the treatment of autoimmune diseases.
    Zagon IS; Donahue RN; Bonneau RH; McLaughlin PJ
    Immunobiology; 2011; 216(1-2):173-83. PubMed ID: 20598772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quaking Inhibits Doxorubicin-Mediated Cardiotoxicity Through Regulation of Cardiac Circular RNA Expression.
    Gupta SK; Garg A; Bär C; Chatterjee S; Foinquinos A; Milting H; Streckfuß-Bömeke K; Fiedler J; Thum T
    Circ Res; 2018 Jan; 122(2):246-254. PubMed ID: 29133306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Yin and Yang of the Opioid Growth Regulatory System: Focus on Diabetes-The Lorenz E. Zimmerman Tribute Lecture.
    Sassani JW; Mc Laughlin PJ; Zagon IS
    J Diabetes Res; 2016; 2016():9703729. PubMed ID: 27703986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Astragalus polysaccharide restores autophagic flux and improves cardiomyocyte function in doxorubicin-induced cardiotoxicity.
    Cao Y; Shen T; Huang X; Lin Y; Chen B; Pang J; Li G; Wang Q; Zohrabian S; Duan C; Ruan Y; Man Y; Wang S; Li J
    Oncotarget; 2017 Jan; 8(3):4837-4848. PubMed ID: 27902477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment with apolipoprotein A1 protects mice against doxorubicin-induced cardiotoxicity in a scavenger receptor class B, type I-dependent manner.
    Durham KK; Kluck G; Mak KC; Deng YD; Trigatti BL
    Am J Physiol Heart Circ Physiol; 2019 Jun; 316(6):H1447-H1457. PubMed ID: 31002281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aging-Associated ALKBH5-m
    Chen R; Zhang G; Sun K; Chen AF
    J Am Heart Assoc; 2024 Jan; 13(1):e031353. PubMed ID: 38156523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.